2022.05.06
2012
The Company was incorporated in Zhangjiang Hi-Tech Park, Shanghai.
2022.05.31
2013
The Company settled in Suzhou Industrial Park.
2022.05.18
2016
The Company completed our Series A funding.
2022.05.18
2017
The Company started the multi-center confirmatory clinical trial in China for TaurusOne®.
2022.05.23
2019
Achieva Medical became our subsidiary through a share swap agreement.The Company completed our Serie···
2022.05.23
2020
On May 15, the Company was listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stoc···
2022.05.23
2021
The Company obtained NMPA's approval for TaurusOne® and TaurusElite®.The Company started a ···
2022.05.31
2022
The Company proposed the establishment of the Interventional Medtech Institute, an Industrial Resear···
2025.02.12
2023
JenaValve Trilogy successfully implanted for the first time in Asia at Queen Elizabeth Hospital, Hon···
2025.02.12
2024
TaurusAtlas Pro® Balloon Dilatation Catheter approved for market launch. TaurusOne® and T···
2025.12.18
2025
TaurusTrio® Transcatheter Aortic Valve System Approved for Market Launch TaurusNXT® Transcathet···